[1. JHA V, GARCIA-GARCIA G, ISEKI K, LI Z, NAICKER S, PLATTNER B, et al. Chronic kidney disease: global dimension and perspectives. The Lancet. 2013;382(9888):260–72.10.1016/S0140-6736(13)60687-X]Search in Google Scholar
[2. CLARKSON KA, ROBINSON K. Life on dialysis: a lived experience. Nephrol Nurs J. 2010;37(1):29–35.]Search in Google Scholar
[3. CHUASUWAN A, POORIPUSSARAKUL S, THAKKINSTIAN A, INGSATHIT A, PATTANAPRATEEP O. Comparisons of quality of life between patients underwent peritoneal dialysis and hemodialysis: a systematic review and meta-analysis. Health Qual. life outcomes. 2020;18(1):1–11.10.1186/s12955-020-01449-2]Search in Google Scholar
[4. MOUSAVI SSB, SOLEIMANI A, MOUSAVI MB. Epidemiology of end-stage renal disease in Iran: a review article. Saudi J Kidney Dis Transpl. 2014;25(3):697–702.10.4103/1319-2442.13224224821181]Search in Google Scholar
[5. BELADI-MOUSAVI SS, ALEMZADEH-ANSARI MJ, ALEMZADEH-ANSARI MH, BELADI-MOUSAVI M. Long-term survival of patients with end-stage renal disease on maintenance hemodialysis: a multicenter study in Iran. Iran J Kidney Dis. 2012;6(6):452–56.]Search in Google Scholar
[6. COZZOLINO M, MANGANO M, STUCCHI A, CICERI P, CONTE F, GALASSI A. Cardiovascular disease in dialysis patients. Nephrol. Dial. Transplant. 2018;33(suppl_3): iii28–iii34.10.1093/ndt/gfy174616881630281132]Search in Google Scholar
[7. COUSER WG, REMUZZI G, MENDIS S, TONELLI M. The contribution of chronic kidney disease to the global burden of major no communicable diseases. Kidney Int. 2011;80(12):1258–70.10.1038/ki.2011.36821993585]Search in Google Scholar
[8. OSSAREH S, FARROKHI F, ZEBARJADI M. Survival of Patients on Hemodialysis and Predictors of Mortality: a Single-Centre Analysis of Time-Dependent Factors. Iran J Kidney Dis. 2016;10(6):369–80.]Search in Google Scholar
[9. SOLTANI Z, RASHEED K, KAPUSTA DR, REISIN E. Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal? Curr. Hypertens. Rep. 2013;15(3):175–81.10.1007/s11906-013-0344-5]Search in Google Scholar
[10. LATIF W, KARABOYAS A, TONG L, WINCHESTER JF, ARRINGTON CJ, PISONI RL, et al. Uric acid levels and all-cause and cardiovascular mortality in the hemodialysis population. Clin J Am Soc Nephrol. 2011;6(10):2470–77.10.2215/CJN.00670111335956221868616]Search in Google Scholar
[11. KIM CS, JIN D-C, YUN YC, BAE EH, MA SK, KIM SW. Relationship between serum uric acid and mortality among hemodialysis patients: Retrospective analysis of Korean end-stage renal disease registry data. Kidney Res Clin Pract. 2017;36(4):368–76.10.23876/j.krcp.2017.36.4.368574304629285429]Search in Google Scholar
[12. PARK C, OBI Y, STREJA E, RHEE CM, CATABAY CJ, VAZIRI ND, et al. Serum uric acid, protein intake and mortality in hemodialysis patients. Nephrol Dial Transplant. 2017;32(10):1750–57.10.1093/ndt/gfw419583768728064158]Search in Google Scholar
[13. BEBERASHVILI I, ERLICH A, AZAR A, SINUANI I, FELDMAN L, GORELIK O, et al. Longitudinal study of serum uric acid, nutritional status, and mortality in maintenance hemodialysis patients. Clin J Am Soc Nephrol. 2016;11(6):1015–23.10.2215/CJN.10400915489175327026520]Search in Google Scholar
[14. LOVRE D, SHAH S, SIHOTA A, FONSECA VA. Managing diabetes and cardiovascular risk in chronic kidney disease patients. Endocrinol Metab Clin. 2018;47(1):237–57.10.1016/j.ecl.2017.10.006580613929407054]Search in Google Scholar
[15. MURRAY T, GOLDBERG M. Chronic interstitial nephritis: etiologic factors. Ann Intern Med. 1975;82(4):453–55.10.7326/0003-4819-82-4-4531119762]Search in Google Scholar
[16. BEBERASHVILI I, SINUANI I, AZAR A, SHAPIRO G, FELDMAN L, STAV K, et al. Serum uric acid as a clinically useful nutritional marker and predictor of outcome in maintenance hemodialysis patients. Nutr J. 2015;31(1):138–47.10.1016/j.nut.2014.06.01225466658]Search in Google Scholar
[17. FIRTH D. Bias Reduction of Maximum Likelihood Estimates. Biometrika 1993; 80(1):27–38.10.1093/biomet/80.1.27]Search in Google Scholar
[18. HEINZE G, PLONER M, DUNKLER D, SOUTHWORTH H, HEINZE MG. “Package ‘logistf” (2020).]Search in Google Scholar
[19. KUCIRKA LM, GRAMS ME, LESSLER J, HALL EC, JAMES N, MASSIE AB, et al. Association of race and age with survival among patients undergoing dialysis. JAMA. 2011;306(6):620–26.10.1001/jama.2011.1127393809821828325]Search in Google Scholar
[20. CHANDRASHEKAR A, RAMAKRISHNAN S, RANGARAJAN D. Survival analysis of patients on maintenance hemodialysis. Indian J Nephrol. 2014;24(4):206–13.10.4103/0971-4065.132985411933225097332]Search in Google Scholar
[21. ECKARDT K-U, KIM J, KRONENBERG F, ALJAMA P, ANKER SD, CANAUD B, et al. Hemoglobin variability does not predict mortality in European hemodialysis patients. J Am Soc Nephrol. 2010;21(10):1765–75.10.1681/ASN.2009101017301353420798262]Search in Google Scholar
[22. GOODKIN DA, FULLER DS, ROBINSON BM, COMBE C, FLUCK R, MENDELSSOHN D, et al. Naturally occurring higher hemoglobin concentration does not increase mortality among hemodialysis patients. J Am Soc Nephrol. 2011;22(2):358–65.10.1681/ASN.2010020173302990821164028]Search in Google Scholar
[23. KREDIET RT, BALAFA O. Cardiovascular risk in the peritoneal dialysis patient. Nat Rev Nephrol. 2010;6(8):451–60.10.1038/nrneph.2010.6820567248]Search in Google Scholar
[24. CHANG TI, STREJA E, SOOHOO M, KIM TW, RHEE CM, KOVESDY CP, et al. Association of serum triglyceride to HDL cholesterol ratio with all-cause and cardiovascular mortality in incident hemodialysis patients. Clin J Am Soc Nephrol. 2017;12(4):591–602.10.2215/CJN.08730816538338828193609]Search in Google Scholar
[25. RAJU D, LALITHA D, KIRANMAYI P. A study of lipid profile and lipid peroxidation in chronic kidney disease with special reference to hemodialysis. J Clinic Res Bioeth. 2013;4(1):1–5.10.4172/2155-9627.1000143]Search in Google Scholar
[26. MIKOLASEVIC I, ŽUTELIJA M, MAVRINAC V, ORLIC L. Dyslipidemia in patients with chronic kidney disease: etiology and management. Int J Nephrol Renovasc dis. 2017; 10:35–45.10.2147/IJNRD.S101808530497128223836]Search in Google Scholar
[27. ZHANG B, GAO C, YANG N, ZHANG W, SONG X, YIN J, et al. Is elevated SUA associated with a worse outcome in young Chinese patients with acute cerebral ischemic stroke? BMC Neurol. 2010;10(1):1–6.10.1186/1471-2377-10-82294960820849639]Search in Google Scholar
[28. CHIQUETE E, RUIZ-SANDOVAL JL, MURILLO-BONILLA LM, ARAUZ A, OROZCO-VALERA DR, OCHOA-GUZMÁN A, et al. Serum uric acid and outcome after acute ischemic stroke: PREMIER study. Cerebrovasc Dis. 2013;35(2):168–74.10.1159/00034660323446426]Search in Google Scholar